Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Icahn School of Medicine at Mount Sinai
Summary
The study team will examine the effects of FDA approved stimulant and non-stimulant medications for ADHD, among youth with ADHD and with and without Oppositional Defiant Disorder (ODD) or Conduct Disorder (CD), on reward systems of the brain using fMRI.
Description
Longitudinal studies have shown that childhood Attention Deficit/Hyperactivity Disorder (ADHD) and child disruptive behavior disorders play an important role in the development of later Substance Use Disorders (SUD). Although available evidence suggests that abnormal reward processing is likely to mediate vulnerability for addiction, the functioning of the brain reward systems in at-risk individuals preceding the exposure to drugs remains largely unknown. Better understanding the baseline characteristics of reward processing in drug-naïve individuals at risk for later SUD is an important initi…
Eligibility
- Age range
- 7–12 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Pre-pubertal (e.g. Tanner stage 1 or 2) * Age 7-12 inclusive * Signed consent/assent * Parent communicates sufficiently in English to provide informed consent and complete assessment instruments; * ADHD as determined by computerized DISC (C-DISC) parent interview * ADHD-Rating Scale-5 total score (interview with parent ) * SNAP ADHD total score (teacher) of 1.5 SD \> age/sex norms * CD or severe ODD: CD or ODD + 2 symptoms of CD on C-DISC * SNAP ODD/CD subscale (parent and teacher) 1.5 SD \> age/sex norms Exclusion Criteria: * Major neurological/medical illness * Histo…
Interventions
- DrugMethylphenidate
stimulant medication
- DrugAtomoxetine
non-stimulant medication
Location
- Icahn School of Medicine at Mount SinaiNew York, New York